nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS3—metabolic syndrome X	0.269	1	CbGaD
Doxorubicin—NDUFS3—Metformin—metabolic syndrome X	0.184	0.333	CbGbCtD
Doxorubicin—NDUFS7—Metformin—metabolic syndrome X	0.184	0.333	CbGbCtD
Doxorubicin—NDUFS2—Metformin—metabolic syndrome X	0.184	0.333	CbGbCtD
Doxorubicin—NOS3—femoral artery—metabolic syndrome X	0.00842	0.121	CbGeAlD
Doxorubicin—NOS1—arteriole—metabolic syndrome X	0.00671	0.0964	CbGeAlD
Doxorubicin—NOS3—arteriole—metabolic syndrome X	0.0051	0.0733	CbGeAlD
Doxorubicin—NOS3—tunica intima—metabolic syndrome X	0.00362	0.052	CbGeAlD
Doxorubicin—NOS1—penis—metabolic syndrome X	0.00352	0.0506	CbGeAlD
Doxorubicin—NOS3—penis—metabolic syndrome X	0.00268	0.0385	CbGeAlD
Doxorubicin—Epirubicin—PLA2G4A—metabolic syndrome X	0.00194	1	CrCbGaD
Doxorubicin—NOS1—artery—metabolic syndrome X	0.00163	0.0234	CbGeAlD
Doxorubicin—NOS1—endothelium—metabolic syndrome X	0.00138	0.0198	CbGeAlD
Doxorubicin—Tooth abscess—Metformin—metabolic syndrome X	0.0013	0.0505	CcSEcCtD
Doxorubicin—NOS1—blood vessel—metabolic syndrome X	0.00127	0.0182	CbGeAlD
Doxorubicin—SLC22A16—kidney—metabolic syndrome X	0.00127	0.0182	CbGeAlD
Doxorubicin—NOS3—artery—metabolic syndrome X	0.00124	0.0178	CbGeAlD
Doxorubicin—NOS3—endothelium—metabolic syndrome X	0.00105	0.015	CbGeAlD
Doxorubicin—ABCB8—kidney—metabolic syndrome X	0.000984	0.0141	CbGeAlD
Doxorubicin—Hypothermia—Metformin—metabolic syndrome X	0.000967	0.0376	CcSEcCtD
Doxorubicin—Body temperature decreased—Metformin—metabolic syndrome X	0.000967	0.0376	CcSEcCtD
Doxorubicin—NOS3—blood vessel—metabolic syndrome X	0.000965	0.0139	CbGeAlD
Doxorubicin—ABCB8—adipose tissue—metabolic syndrome X	0.000887	0.0127	CbGeAlD
Doxorubicin—CBR3—adipose tissue—metabolic syndrome X	0.000854	0.0123	CbGeAlD
Doxorubicin—Nail disorder—Metformin—metabolic syndrome X	0.000836	0.0325	CcSEcCtD
Doxorubicin—AKR1A1—cardiovascular system—metabolic syndrome X	0.000747	0.0107	CbGeAlD
Doxorubicin—AKR1A1—kidney—metabolic syndrome X	0.000731	0.0105	CbGeAlD
Doxorubicin—Fungal infection—Metformin—metabolic syndrome X	0.000702	0.0273	CcSEcCtD
Doxorubicin—NDUFS7—cardiovascular system—metabolic syndrome X	0.000679	0.00976	CbGeAlD
Doxorubicin—NDUFS7—kidney—metabolic syndrome X	0.000665	0.00955	CbGeAlD
Doxorubicin—Rigors—Metformin—metabolic syndrome X	0.000664	0.0259	CcSEcCtD
Doxorubicin—AKR1A1—adipose tissue—metabolic syndrome X	0.000659	0.00947	CbGeAlD
Doxorubicin—Blood disorder—Metformin—metabolic syndrome X	0.000649	0.0253	CcSEcCtD
Doxorubicin—ABCB8—liver—metabolic syndrome X	0.000622	0.00893	CbGeAlD
Doxorubicin—AURKA—kidney—metabolic syndrome X	0.000618	0.00888	CbGeAlD
Doxorubicin—NDUFS7—adipose tissue—metabolic syndrome X	0.000599	0.00861	CbGeAlD
Doxorubicin—NOS1—cardiovascular system—metabolic syndrome X	0.000566	0.00814	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—metabolic syndrome X	0.000563	0.00809	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—metabolic syndrome X	0.000556	0.00799	CbGeAlD
Doxorubicin—NOS1—kidney—metabolic syndrome X	0.000554	0.00796	CbGeAlD
Doxorubicin—NDUFS2—kidney—metabolic syndrome X	0.000551	0.00791	CbGeAlD
Doxorubicin—NDUFS3—kidney—metabolic syndrome X	0.000544	0.00782	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—metabolic syndrome X	0.000515	0.0074	CbGeAlD
Doxorubicin—Neuropathy—Metformin—metabolic syndrome X	0.000509	0.0198	CcSEcCtD
Doxorubicin—ABCC6—kidney—metabolic syndrome X	0.000504	0.00724	CbGeAlD
Doxorubicin—NDUFS2—adipose tissue—metabolic syndrome X	0.000496	0.00713	CbGeAlD
Doxorubicin—NDUFS3—adipose tissue—metabolic syndrome X	0.00049	0.00704	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—metabolic syndrome X	0.000485	0.00696	CbGeAlD
Doxorubicin—YWHAG—kidney—metabolic syndrome X	0.000474	0.00681	CbGeAlD
Doxorubicin—DHCR7—adipose tissue—metabolic syndrome X	0.000466	0.00669	CbGeAlD
Doxorubicin—XDH—kidney—metabolic syndrome X	0.000463	0.00664	CbGeAlD
Doxorubicin—AKR1A1—liver—metabolic syndrome X	0.000462	0.00664	CbGeAlD
Doxorubicin—ABCC6—adipose tissue—metabolic syndrome X	0.000454	0.00652	CbGeAlD
Doxorubicin—RALBP1—cardiovascular system—metabolic syndrome X	0.000438	0.00629	CbGeAlD
Doxorubicin—NOS3—cardiovascular system—metabolic syndrome X	0.000431	0.00619	CbGeAlD
Doxorubicin—RALBP1—kidney—metabolic syndrome X	0.000428	0.00615	CbGeAlD
Doxorubicin—YWHAG—adipose tissue—metabolic syndrome X	0.000427	0.00614	CbGeAlD
Doxorubicin—NOS3—kidney—metabolic syndrome X	0.000421	0.00605	CbGeAlD
Doxorubicin—NDUFS7—liver—metabolic syndrome X	0.00042	0.00604	CbGeAlD
Doxorubicin—Renal impairment—Metformin—metabolic syndrome X	0.000413	0.0161	CcSEcCtD
Doxorubicin—CBR1—cardiovascular system—metabolic syndrome X	0.000409	0.00587	CbGeAlD
Doxorubicin—Hypoglycaemia—Metformin—metabolic syndrome X	0.000403	0.0157	CcSEcCtD
Doxorubicin—Lethargy—Metformin—metabolic syndrome X	0.000401	0.0156	CcSEcCtD
Doxorubicin—CBR1—kidney—metabolic syndrome X	0.0004	0.00574	CbGeAlD
Doxorubicin—Pain in extremity—Metformin—metabolic syndrome X	0.000393	0.0153	CcSEcCtD
Doxorubicin—AURKA—liver—metabolic syndrome X	0.000391	0.00561	CbGeAlD
Doxorubicin—Migraine—Metformin—metabolic syndrome X	0.000387	0.0151	CcSEcCtD
Doxorubicin—RALBP1—adipose tissue—metabolic syndrome X	0.000386	0.00555	CbGeAlD
Doxorubicin—Dehydration—Metformin—metabolic syndrome X	0.000366	0.0142	CcSEcCtD
Doxorubicin—Liver function test abnormal—Metformin—metabolic syndrome X	0.000363	0.0141	CcSEcCtD
Doxorubicin—CBR1—adipose tissue—metabolic syndrome X	0.00036	0.00518	CbGeAlD
Doxorubicin—Abdominal pain upper—Metformin—metabolic syndrome X	0.000359	0.014	CcSEcCtD
Doxorubicin—AKR1C3—adipose tissue—metabolic syndrome X	0.000356	0.00511	CbGeAlD
Doxorubicin—Breast disorder—Metformin—metabolic syndrome X	0.000356	0.0138	CcSEcCtD
Doxorubicin—Nasopharyngitis—Metformin—metabolic syndrome X	0.000352	0.0137	CcSEcCtD
Doxorubicin—NDUFS2—liver—metabolic syndrome X	0.000348	0.005	CbGeAlD
Doxorubicin—NDUFS3—liver—metabolic syndrome X	0.000344	0.00494	CbGeAlD
Doxorubicin—Abdominal distension—Metformin—metabolic syndrome X	0.000342	0.0133	CcSEcCtD
Doxorubicin—Influenza—Metformin—metabolic syndrome X	0.00034	0.0132	CcSEcCtD
Doxorubicin—Pancreatitis—Metformin—metabolic syndrome X	0.000333	0.013	CcSEcCtD
Doxorubicin—Angina pectoris—Metformin—metabolic syndrome X	0.000331	0.0129	CcSEcCtD
Doxorubicin—NQO1—cardiovascular system—metabolic syndrome X	0.000327	0.0047	CbGeAlD
Doxorubicin—DHCR7—liver—metabolic syndrome X	0.000327	0.00469	CbGeAlD
Doxorubicin—POR—adipose tissue—metabolic syndrome X	0.000325	0.00467	CbGeAlD
Doxorubicin—NQO1—kidney—metabolic syndrome X	0.00032	0.0046	CbGeAlD
Doxorubicin—ABCC6—liver—metabolic syndrome X	0.000318	0.00457	CbGeAlD
Doxorubicin—Neutropenia—Metformin—metabolic syndrome X	0.000318	0.0124	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000316	0.0123	CcSEcCtD
Doxorubicin—Drowsiness—Metformin—metabolic syndrome X	0.000303	0.0118	CcSEcCtD
Doxorubicin—Infestation—Metformin—metabolic syndrome X	0.000303	0.0118	CcSEcCtD
Doxorubicin—Infestation NOS—Metformin—metabolic syndrome X	0.000303	0.0118	CcSEcCtD
Doxorubicin—TOP2A—adipose tissue—metabolic syndrome X	0.000303	0.00435	CbGeAlD
Doxorubicin—YWHAG—liver—metabolic syndrome X	0.0003	0.00431	CbGeAlD
Doxorubicin—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000297	0.0116	CcSEcCtD
Doxorubicin—XDH—liver—metabolic syndrome X	0.000292	0.0042	CbGeAlD
Doxorubicin—NQO1—adipose tissue—metabolic syndrome X	0.000289	0.00415	CbGeAlD
Doxorubicin—ABCC3—kidney—metabolic syndrome X	0.000288	0.00413	CbGeAlD
Doxorubicin—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000287	0.0112	CcSEcCtD
Doxorubicin—ABCC10—kidney—metabolic syndrome X	0.000286	0.00411	CbGeAlD
Doxorubicin—ABCB11—liver—metabolic syndrome X	0.000286	0.0041	CbGeAlD
Doxorubicin—Bradycardia—Metformin—metabolic syndrome X	0.000277	0.0108	CcSEcCtD
Doxorubicin—Rhinitis—Metformin—metabolic syndrome X	0.000273	0.0106	CcSEcCtD
Doxorubicin—Hepatitis—Metformin—metabolic syndrome X	0.000272	0.0106	CcSEcCtD
Doxorubicin—Hypoaesthesia—Metformin—metabolic syndrome X	0.000271	0.0105	CcSEcCtD
Doxorubicin—RALBP1—liver—metabolic syndrome X	0.000271	0.00389	CbGeAlD
Doxorubicin—Oedema peripheral—Metformin—metabolic syndrome X	0.000268	0.0104	CcSEcCtD
Doxorubicin—Connective tissue disorder—Metformin—metabolic syndrome X	0.000267	0.0104	CcSEcCtD
Doxorubicin—NOS3—liver—metabolic syndrome X	0.000266	0.00383	CbGeAlD
Doxorubicin—ABCC3—adipose tissue—metabolic syndrome X	0.000259	0.00372	CbGeAlD
Doxorubicin—ABCC10—adipose tissue—metabolic syndrome X	0.000258	0.0037	CbGeAlD
Doxorubicin—Eye disorder—Metformin—metabolic syndrome X	0.000254	0.0099	CcSEcCtD
Doxorubicin—CBR1—liver—metabolic syndrome X	0.000253	0.00363	CbGeAlD
Doxorubicin—Flushing—Metformin—metabolic syndrome X	0.000253	0.00984	CcSEcCtD
Doxorubicin—Cardiac disorder—Metformin—metabolic syndrome X	0.000253	0.00984	CcSEcCtD
Doxorubicin—AKR1C3—liver—metabolic syndrome X	0.00025	0.00359	CbGeAlD
Doxorubicin—Angiopathy—Metformin—metabolic syndrome X	0.000247	0.00962	CcSEcCtD
Doxorubicin—Immune system disorder—Metformin—metabolic syndrome X	0.000246	0.00957	CcSEcCtD
Doxorubicin—Mediastinal disorder—Metformin—metabolic syndrome X	0.000245	0.00955	CcSEcCtD
Doxorubicin—Chills—Metformin—metabolic syndrome X	0.000244	0.00951	CcSEcCtD
Doxorubicin—Erythema—Metformin—metabolic syndrome X	0.000237	0.00923	CcSEcCtD
Doxorubicin—Malnutrition—Metformin—metabolic syndrome X	0.000237	0.00923	CcSEcCtD
Doxorubicin—Flatulence—Metformin—metabolic syndrome X	0.000233	0.00909	CcSEcCtD
Doxorubicin—Dysgeusia—Metformin—metabolic syndrome X	0.000232	0.00903	CcSEcCtD
Doxorubicin—CYP1B1—cardiovascular system—metabolic syndrome X	0.00023	0.0033	CbGeAlD
Doxorubicin—ABCC2—kidney—metabolic syndrome X	0.00023	0.0033	CbGeAlD
Doxorubicin—POR—liver—metabolic syndrome X	0.000228	0.00327	CbGeAlD
Doxorubicin—Muscle spasms—Metformin—metabolic syndrome X	0.000228	0.00887	CcSEcCtD
Doxorubicin—CYP1B1—kidney—metabolic syndrome X	0.000225	0.00323	CbGeAlD
Doxorubicin—Vision blurred—Metformin—metabolic syndrome X	0.000223	0.0087	CcSEcCtD
Doxorubicin—Ill-defined disorder—Metformin—metabolic syndrome X	0.00022	0.00856	CcSEcCtD
Doxorubicin—Malaise—Metformin—metabolic syndrome X	0.000214	0.00832	CcSEcCtD
Doxorubicin—Syncope—Metformin—metabolic syndrome X	0.000212	0.00827	CcSEcCtD
Doxorubicin—Palpitations—Metformin—metabolic syndrome X	0.000209	0.00815	CcSEcCtD
Doxorubicin—Loss of consciousness—Metformin—metabolic syndrome X	0.000208	0.00811	CcSEcCtD
Doxorubicin—Hypertension—Metformin—metabolic syndrome X	0.000205	0.00797	CcSEcCtD
Doxorubicin—CYP1B1—adipose tissue—metabolic syndrome X	0.000203	0.00291	CbGeAlD
Doxorubicin—NQO1—liver—metabolic syndrome X	0.000202	0.00291	CbGeAlD
Doxorubicin—Chest pain—Metformin—metabolic syndrome X	0.000202	0.00785	CcSEcCtD
Doxorubicin—Myalgia—Metformin—metabolic syndrome X	0.000202	0.00785	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0002	0.0078	CcSEcCtD
Doxorubicin—Discomfort—Metformin—metabolic syndrome X	0.000199	0.00776	CcSEcCtD
Doxorubicin—Oedema—Metformin—metabolic syndrome X	0.000193	0.00753	CcSEcCtD
Doxorubicin—Infection—Metformin—metabolic syndrome X	0.000192	0.00748	CcSEcCtD
Doxorubicin—Shock—Metformin—metabolic syndrome X	0.00019	0.00741	CcSEcCtD
Doxorubicin—Nervous system disorder—Metformin—metabolic syndrome X	0.00019	0.00738	CcSEcCtD
Doxorubicin—Thrombocytopenia—Metformin—metabolic syndrome X	0.000189	0.00737	CcSEcCtD
Doxorubicin—ABCB1—blood vessel—metabolic syndrome X	0.000189	0.00272	CbGeAlD
Doxorubicin—Skin disorder—Metformin—metabolic syndrome X	0.000188	0.00731	CcSEcCtD
Doxorubicin—Hyperhidrosis—Metformin—metabolic syndrome X	0.000187	0.00728	CcSEcCtD
Doxorubicin—Anorexia—Metformin—metabolic syndrome X	0.000184	0.00718	CcSEcCtD
Doxorubicin—ABCC1—adipose tissue—metabolic syndrome X	0.000182	0.00262	CbGeAlD
Doxorubicin—ABCC3—liver—metabolic syndrome X	0.000182	0.00261	CbGeAlD
Doxorubicin—ABCC10—liver—metabolic syndrome X	0.000181	0.0026	CbGeAlD
Doxorubicin—Hypotension—Metformin—metabolic syndrome X	0.000181	0.00704	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000176	0.00686	CcSEcCtD
Doxorubicin—Paraesthesia—Metformin—metabolic syndrome X	0.000174	0.00676	CcSEcCtD
Doxorubicin—Dyspnoea—Metformin—metabolic syndrome X	0.000172	0.00671	CcSEcCtD
Doxorubicin—Somnolence—Metformin—metabolic syndrome X	0.000172	0.00669	CcSEcCtD
Doxorubicin—Dyspepsia—Metformin—metabolic syndrome X	0.00017	0.00663	CcSEcCtD
Doxorubicin—Decreased appetite—Metformin—metabolic syndrome X	0.000168	0.00655	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000167	0.0065	CcSEcCtD
Doxorubicin—Fatigue—Metformin—metabolic syndrome X	0.000167	0.00649	CcSEcCtD
Doxorubicin—Constipation—Metformin—metabolic syndrome X	0.000165	0.00644	CcSEcCtD
Doxorubicin—Feeling abnormal—Metformin—metabolic syndrome X	0.000159	0.0062	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000158	0.00616	CcSEcCtD
Doxorubicin—CYP2B6—cardiovascular system—metabolic syndrome X	0.000158	0.00227	CbGeAlD
Doxorubicin—CYP2B6—kidney—metabolic syndrome X	0.000155	0.00222	CbGeAlD
Doxorubicin—Urticaria—Metformin—metabolic syndrome X	0.000154	0.00598	CcSEcCtD
Doxorubicin—Abdominal pain—Metformin—metabolic syndrome X	0.000153	0.00595	CcSEcCtD
Doxorubicin—ABCG2—adipose tissue—metabolic syndrome X	0.000151	0.00217	CbGeAlD
Doxorubicin—ABCC2—liver—metabolic syndrome X	0.000145	0.00209	CbGeAlD
Doxorubicin—CYP1B1—liver—metabolic syndrome X	0.000142	0.00204	CbGeAlD
Doxorubicin—Asthenia—Metformin—metabolic syndrome X	0.000139	0.0054	CcSEcCtD
Doxorubicin—Pruritus—Metformin—metabolic syndrome X	0.000137	0.00533	CcSEcCtD
Doxorubicin—Diarrhoea—Metformin—metabolic syndrome X	0.000132	0.00515	CcSEcCtD
Doxorubicin—ABCC1—liver—metabolic syndrome X	0.000128	0.00184	CbGeAlD
Doxorubicin—Dizziness—Metformin—metabolic syndrome X	0.000128	0.00498	CcSEcCtD
Doxorubicin—Vomiting—Metformin—metabolic syndrome X	0.000123	0.00479	CcSEcCtD
Doxorubicin—Rash—Metformin—metabolic syndrome X	0.000122	0.00475	CcSEcCtD
Doxorubicin—Dermatitis—Metformin—metabolic syndrome X	0.000122	0.00474	CcSEcCtD
Doxorubicin—Headache—Metformin—metabolic syndrome X	0.000121	0.00472	CcSEcCtD
Doxorubicin—CYP3A4—kidney—metabolic syndrome X	0.000117	0.00168	CbGeAlD
Doxorubicin—Nausea—Metformin—metabolic syndrome X	0.000115	0.00447	CcSEcCtD
Doxorubicin—CYP2D6—kidney—metabolic syndrome X	0.000115	0.00165	CbGeAlD
Doxorubicin—ABCG2—liver—metabolic syndrome X	0.000106	0.00152	CbGeAlD
Doxorubicin—CYP2B6—liver—metabolic syndrome X	9.77e-05	0.0014	CbGeAlD
Doxorubicin—ABCB1—cardiovascular system—metabolic syndrome X	8.44e-05	0.00121	CbGeAlD
Doxorubicin—ABCB1—kidney—metabolic syndrome X	8.26e-05	0.00119	CbGeAlD
Doxorubicin—ABCB1—adipose tissue—metabolic syndrome X	7.45e-05	0.00107	CbGeAlD
Doxorubicin—CYP3A4—liver—metabolic syndrome X	7.38e-05	0.00106	CbGeAlD
Doxorubicin—CYP2D6—liver—metabolic syndrome X	7.26e-05	0.00104	CbGeAlD
Doxorubicin—ABCB1—liver—metabolic syndrome X	5.22e-05	0.00075	CbGeAlD
Doxorubicin—ABCB11—Metabolism—APOE—metabolic syndrome X	5.31e-06	6.51e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—metabolic syndrome X	5.3e-06	6.51e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOA1—metabolic syndrome X	5.24e-06	6.43e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AGT—metabolic syndrome X	5.19e-06	6.37e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	5.17e-06	6.34e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GOT1—metabolic syndrome X	5.16e-06	6.33e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GGT1—metabolic syndrome X	5.16e-06	6.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—metabolic syndrome X	5.12e-06	6.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—metabolic syndrome X	5.09e-06	6.24e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SERPINE1—metabolic syndrome X	5.08e-06	6.23e-05	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—metabolic syndrome X	5.07e-06	6.22e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	5.06e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NAMPT—metabolic syndrome X	5.06e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	5.05e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOA1—metabolic syndrome X	5.03e-06	6.17e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LIPC—metabolic syndrome X	5.03e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GCK—metabolic syndrome X	5.03e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FMO3—metabolic syndrome X	5e-06	6.14e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOC3—metabolic syndrome X	4.99e-06	6.13e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—metabolic syndrome X	4.98e-06	6.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOB—metabolic syndrome X	4.98e-06	6.11e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—metabolic syndrome X	4.98e-06	6.11e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—metabolic syndrome X	4.93e-06	6.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—G6PD—metabolic syndrome X	4.89e-06	6e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IRS1—metabolic syndrome X	4.88e-06	5.98e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOS3—metabolic syndrome X	4.85e-06	5.95e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CETP—metabolic syndrome X	4.85e-06	5.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PLA2G4A—metabolic syndrome X	4.84e-06	5.94e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOB—metabolic syndrome X	4.82e-06	5.91e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HDAC3—metabolic syndrome X	4.77e-06	5.86e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—metabolic syndrome X	4.76e-06	5.84e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LPL—metabolic syndrome X	4.75e-06	5.83e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—metabolic syndrome X	4.73e-06	5.81e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	4.72e-06	5.79e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOA1—metabolic syndrome X	4.7e-06	5.77e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PLA2G4A—metabolic syndrome X	4.68e-06	5.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—INS—metabolic syndrome X	4.67e-06	5.73e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCKR—metabolic syndrome X	4.67e-06	5.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPA—metabolic syndrome X	4.67e-06	5.72e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SCARB1—metabolic syndrome X	4.64e-06	5.7e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—metabolic syndrome X	4.62e-06	5.67e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—G6PD—metabolic syndrome X	4.61e-06	5.65e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LPL—metabolic syndrome X	4.6e-06	5.64e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—metabolic syndrome X	4.6e-06	5.64e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—metabolic syndrome X	4.59e-06	5.63e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—metabolic syndrome X	4.58e-06	5.62e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—INS—metabolic syndrome X	4.53e-06	5.56e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1—metabolic syndrome X	4.52e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	4.52e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CD36—metabolic syndrome X	4.52e-06	5.54e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SREBF1—metabolic syndrome X	4.51e-06	5.53e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	4.5e-06	5.52e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—metabolic syndrome X	4.48e-06	5.5e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOA5—metabolic syndrome X	4.47e-06	5.49e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	4.46e-06	5.47e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	4.46e-06	5.47e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—metabolic syndrome X	4.43e-06	5.43e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPA—metabolic syndrome X	4.4e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCKR—metabolic syndrome X	4.4e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GOT2—metabolic syndrome X	4.38e-06	5.38e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMGCR—metabolic syndrome X	4.38e-06	5.38e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOB—metabolic syndrome X	4.38e-06	5.37e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CD36—metabolic syndrome X	4.37e-06	5.36e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—metabolic syndrome X	4.36e-06	5.35e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—INS—metabolic syndrome X	4.35e-06	5.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SERPINE1—metabolic syndrome X	4.29e-06	5.26e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	4.27e-06	5.23e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLA2G4A—metabolic syndrome X	4.26e-06	5.23e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	4.26e-06	5.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IRS1—metabolic syndrome X	4.25e-06	5.21e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOA5—metabolic syndrome X	4.22e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARA—metabolic syndrome X	4.2e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	4.19e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LPL—metabolic syndrome X	4.18e-06	5.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TRIB3—metabolic syndrome X	4.16e-06	5.1e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—metabolic syndrome X	4.15e-06	5.1e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AGT—metabolic syndrome X	4.07e-06	4.99e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—INS—metabolic syndrome X	4.07e-06	4.99e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARA—metabolic syndrome X	4.06e-06	4.98e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—metabolic syndrome X	4.02e-06	4.93e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	4e-06	4.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—metabolic syndrome X	3.99e-06	4.89e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—metabolic syndrome X	3.98e-06	4.89e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CD36—metabolic syndrome X	3.98e-06	4.88e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NOS3—metabolic syndrome X	3.97e-06	4.88e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOA1—metabolic syndrome X	3.94e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AGT—metabolic syndrome X	3.93e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	3.92e-06	4.81e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCA1—metabolic syndrome X	3.91e-06	4.79e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC2A4—metabolic syndrome X	3.91e-06	4.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—metabolic syndrome X	3.87e-06	4.75e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—metabolic syndrome X	3.85e-06	4.73e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOA1—metabolic syndrome X	3.81e-06	4.67e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—metabolic syndrome X	3.81e-06	4.67e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GGT1—metabolic syndrome X	3.78e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GOT1—metabolic syndrome X	3.78e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—metabolic syndrome X	3.75e-06	4.61e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SERPINE1—metabolic syndrome X	3.73e-06	4.58e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NAMPT—metabolic syndrome X	3.73e-06	4.58e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCK—metabolic syndrome X	3.71e-06	4.55e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LIPC—metabolic syndrome X	3.71e-06	4.55e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARA—metabolic syndrome X	3.7e-06	4.53e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOC3—metabolic syndrome X	3.68e-06	4.52e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—metabolic syndrome X	3.64e-06	4.46e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGT—metabolic syndrome X	3.58e-06	4.39e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CETP—metabolic syndrome X	3.58e-06	4.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FABP4—metabolic syndrome X	3.57e-06	4.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—metabolic syndrome X	3.57e-06	4.37e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	3.51e-06	4.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.51e-06	4.31e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—metabolic syndrome X	3.51e-06	4.3e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCK—metabolic syndrome X	3.49e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LIPC—metabolic syndrome X	3.49e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—metabolic syndrome X	3.49e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—metabolic syndrome X	3.47e-06	4.26e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOC3—metabolic syndrome X	3.47e-06	4.26e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOA1—metabolic syndrome X	3.47e-06	4.25e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—metabolic syndrome X	3.46e-06	4.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—metabolic syndrome X	3.45e-06	4.23e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SCARB1—metabolic syndrome X	3.42e-06	4.2e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INS—metabolic syndrome X	3.4e-06	4.18e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	3.38e-06	4.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CETP—metabolic syndrome X	3.37e-06	4.13e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—metabolic syndrome X	3.36e-06	4.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SREBF1—metabolic syndrome X	3.32e-06	4.08e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INS—metabolic syndrome X	3.29e-06	4.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—metabolic syndrome X	3.26e-06	4e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMGCR—metabolic syndrome X	3.23e-06	3.97e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT2—metabolic syndrome X	3.23e-06	3.97e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	3.23e-06	3.96e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOB—metabolic syndrome X	3.21e-06	3.94e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—metabolic syndrome X	3.21e-06	3.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—metabolic syndrome X	3.18e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.17e-06	3.89e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	3.13e-06	3.84e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLA2G4A—metabolic syndrome X	3.12e-06	3.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—metabolic syndrome X	3.12e-06	3.83e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LPL—metabolic syndrome X	3.07e-06	3.76e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—metabolic syndrome X	3.05e-06	3.75e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	3.05e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT2—metabolic syndrome X	3.05e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—metabolic syndrome X	3.02e-06	3.7e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—G6PD—metabolic syndrome X	3.01e-06	3.7e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INS—metabolic syndrome X	3e-06	3.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—metabolic syndrome X	2.99e-06	3.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	2.94e-06	3.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—metabolic syndrome X	2.92e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CD36—metabolic syndrome X	2.91e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—metabolic syndrome X	2.89e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCA1—metabolic syndrome X	2.88e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	2.88e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPA—metabolic syndrome X	2.87e-06	3.53e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCKR—metabolic syndrome X	2.87e-06	3.53e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GGT1—metabolic syndrome X	2.79e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GOT1—metabolic syndrome X	2.79e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	2.78e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—metabolic syndrome X	2.76e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA5—metabolic syndrome X	2.76e-06	3.38e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—metabolic syndrome X	2.75e-06	3.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—metabolic syndrome X	2.73e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	2.72e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	2.72e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—metabolic syndrome X	2.71e-06	3.32e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARA—metabolic syndrome X	2.71e-06	3.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—metabolic syndrome X	2.69e-06	3.3e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—metabolic syndrome X	2.67e-06	3.27e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—metabolic syndrome X	2.64e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GOT1—metabolic syndrome X	2.63e-06	3.23e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GGT1—metabolic syndrome X	2.63e-06	3.23e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—metabolic syndrome X	2.63e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGT—metabolic syndrome X	2.62e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—metabolic syndrome X	2.57e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.56e-06	3.14e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOA1—metabolic syndrome X	2.54e-06	3.12e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—metabolic syndrome X	2.48e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—metabolic syndrome X	2.42e-06	2.96e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—metabolic syndrome X	2.4e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOB—metabolic syndrome X	2.37e-06	2.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—metabolic syndrome X	2.36e-06	2.89e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	2.3e-06	2.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.3e-06	2.82e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.28e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.28e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.27e-06	2.78e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPL—metabolic syndrome X	2.26e-06	2.77e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—metabolic syndrome X	2.25e-06	2.76e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—metabolic syndrome X	2.24e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOB—metabolic syndrome X	2.23e-06	2.74e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—metabolic syndrome X	2.23e-06	2.73e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.2e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INS—metabolic syndrome X	2.2e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	2.17e-06	2.66e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CD36—metabolic syndrome X	2.15e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPL—metabolic syndrome X	2.13e-06	2.61e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.11e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	2.05e-06	2.51e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—metabolic syndrome X	2.04e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CD36—metabolic syndrome X	2.03e-06	2.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—metabolic syndrome X	2.01e-06	2.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARA—metabolic syndrome X	2e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.99e-06	2.44e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.99e-06	2.44e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGT—metabolic syndrome X	1.94e-06	2.37e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—metabolic syndrome X	1.93e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—metabolic syndrome X	1.9e-06	2.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—metabolic syndrome X	1.88e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.88e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.87e-06	2.3e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—metabolic syndrome X	1.83e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.82e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.79e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—metabolic syndrome X	1.78e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.78e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.78e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOA1—metabolic syndrome X	1.77e-06	2.17e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—metabolic syndrome X	1.76e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—metabolic syndrome X	1.75e-06	2.15e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.72e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.72e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.65e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—metabolic syndrome X	1.64e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INS—metabolic syndrome X	1.62e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.56e-06	1.91e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INS—metabolic syndrome X	1.53e-06	1.87e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—metabolic syndrome X	1.48e-06	1.82e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.46e-06	1.79e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.42e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.42e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—metabolic syndrome X	1.4e-06	1.72e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.39e-06	1.71e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—metabolic syndrome X	1.37e-06	1.68e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—metabolic syndrome X	1.34e-06	1.64e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—metabolic syndrome X	1.33e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.32e-06	1.62e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.3e-06	1.59e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.23e-06	1.51e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	1.22e-06	1.5e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—metabolic syndrome X	1.21e-06	1.48e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.19e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.17e-06	1.43e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.15e-06	1.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.02e-06	1.25e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INS—metabolic syndrome X	9.98e-07	1.22e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—metabolic syndrome X	9.15e-07	1.12e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—metabolic syndrome X	8.85e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—metabolic syndrome X	8.75e-07	1.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	8e-07	9.82e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—metabolic syndrome X	6.53e-07	8.01e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—metabolic syndrome X	6.15e-07	7.55e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—metabolic syndrome X	4.02e-07	4.93e-06	CbGpPWpGaD
